0

Home > Drug Category > Antidepressant Drugs > Parnate and Equivalent

Parnate (Tranylcypromine) Information

Parnate (tranylcypromine sulphate) is a prescription medication classified as a non-selective, irreversible Monoamine Oxidase Inhibitor (MAOI). It is reserved for the treatment of Refractory Major Depressive Disorder (MDD)—severe depression that has not responded adequately to other classes of antidepressants, such as SSRIs, SNRIs, or TCAs. Parnate is one of the most potent and effective antidepressants available. However, its use requires meticulous patient adherence to strict dietary and medication restrictions due to its severe interaction risks. It is considered a specialized treatment, managed primarily by psychiatrists with expertise in MAOI therapy.

The mechanism of action for tranylcypromine is based on its potent and irreversible inhibition of monoamine oxidase enzymes. It irreversibly inhibits both MAO-A and MAO-B. The MAO-A enzyme metabolizes norepinephrine (NE) and serotonin (5-HT), and the MAO-B enzyme primarily metabolizes dopamine (DA) and phenylethylamine (PEA). By non-selectively blocking both forms of the enzyme, tranylcypromine dramatically increases the concentration and activity of all three major monoamine neurotransmitters (NE, 5-HT, and DA) in the brain. This robust increase in monoamine levels provides its powerful antidepressant effect. Because the inhibition is permanent, the body must synthesize new MAO enzymes for the drug's effect to subside, which takes approximately 10 to 14 days; this long duration necessitates the use of a 14-day washout period when switching medications.

Parnate is available in Canada as a prescription-only tablet for use in adults 18 years of age and older. Dosing is highly individualized and must be initiated at a low dose (e.g., 10 mg/day) and slowly titrated up, typically in divided doses throughout the day, up to a maximum of 60 mg/day. Due to its stimulating and activating properties, the final dose of the day is often taken no later than mid-afternoon to prevent treatment-emergent insomnia.

Parnate Side Effects

While Parnate is highly effective, it has a significant side effect burden. It is associated with some of the most serious safety risks in psychiatric medicine. The most common side effect is orthostatic hypotension (a drop in blood pressure upon standing), which can cause dizziness, lightheadedness, and falls, especially in the elderly. Other common side effects include insomnia, headache, dry mouth, edema (swelling of the ankles/feet), and sexual dysfunction.

However, more serious side effects are a significant concern and require immediate medical attention:

• Hypertensive Crisis: This is a potentially fatal, rapid, and severe elevation in blood pressure caused by the ingestion of tyramine-rich foods (e.g., aged cheeses, cured meats, red wine, tap beer) or the co-administration of sympathomimetic drugs (e.g., pseudoephedrine, phenylephrine). Symptoms include a sudden, explosive headache, chest pain, profuse sweating, and palpitations.

• Mania/Hypomania and Psychosis: The drug's potent activating effects can trigger manic or hypomanic episodes in patients with undiagnosed bipolar disorder or precipitate psychotic symptoms in susceptible individuals.

• Serotonin Syndrome: This is a potentially life-threatening reaction resulting from an excessive increase in serotonin, caused by combining Parnate with virtually any other serotonergic drug (e.g., SSRIs, SNRIs, TCAs, triptans, pethidine, or dextromethorphan). Symptoms may include agitation, hallucinations, rapid heart rate, fever, and muscle rigidity.

• Suicidality and Worsening of Depression (Boxed Warning): Like all antidepressants, Parnate carries a strong warning for increasing the risk of suicidal thoughts and behaviour, particularly in young adults (under 25), especially during the initial phase of treatment.

Parnate Precautions

Before taking Parnate, it is essential to have a thorough discussion with a healthcare provider about your medical history and any other medications you are taking. Parnate is absolutely contraindicated for use with a vast range of drugs, including all other antidepressants (SSRIs, SNRIs, TCAs, etc.), pethidine, most over-the-counter cold/flu medications containing sympathomimetic amines (e.g., pseudoephedrine), and certain dietary supplements; a mandatory 14-day washout period is required when switching to or from these medications. Patients must adhere to a strict, lifelong, low-tyramine diet to avoid a potentially fatal hypertensive crisis; this requires meticulous avoidance of aged, cured, fermented, and spoiled foods and beverages (e.g., aged cheeses, soy sauce, pickled herring, tap beer). Due to the risk of orthostatic hypotension and hypertensive reactions, Parnate is contraindicated in patients with unmanaged hypertension or a history of pheochromocytoma, and caution is required in patients with cardiovascular or cerebrovascular disease. The drug should be used with extreme caution in patients with a history of seizures, and it must never be used in children or adolescents. The dosage must be reduced in patients with kidney or liver impairment. Abrupt discontinuation of Parnate must be avoided, as it can lead to severe withdrawal symptoms, including psychosis, and the dose must be tapered extremely slowly under medical supervision. If you are pregnant or breastfeeding, the risks and benefits must be carefully weighed with your doctor.

Do I need a prescription to order Parnate?

Yes, a prescription is required from your physician to order Parnate.